|
|
- NHS Regional Offices
- NHS Foundation Trusts (England) - Medical Director
- NHS Trusts (England) - Medical Director
|
|
|
- MHRA (Medicines) Drug Alerts (Various Recipients)
- Other contacts
- Independent Healthcare Providers (registered with CAS)
- Clinical Commissioning Groups
- NHS Foundation Trusts (England) - Chief Executive
- MHRA (Medicines) Drug Alerts - Non-NHS Recipients
- Territorial CMOs in Northern Ireland, Scotland & Wales
- Regional Directors of Public Health
- Director of Public Health
- NHS Trusts (England) - Chief Executive
- GP - Locum
- NHS 111 and Out of hours providers
- Dispensing GP Practices
- DHSC Supply Disruption - Medicines
- Primary Care Networks
|
| Action category: |
|
Class 3: Action within 5 days
|
| Title: |
|
CLASS 3 DRUG ALERT, ACTION WITHIN 5 DAYS, THERAMEX IRELAND LTD T/A THERAMEX HQ UK LTD, ALFA D 0.25 MICROGRAM CAPSULES, PL 49876/0001 AND ALFA D 1 MICROGRAM CAPSULES, PL 49876/0003
|
| Broadcast content: |
|
Theramex Ireland Ltd T/A Theramex HQ UK
Ltd has informed us of an issue related to error in the decommissioning of the
above batch. Upon decommissioning at the pharmacy and when scanning the
serialised 2D code, the status of packs may report as ‘EXPORT’. Although there
is no risk to product quality, any remaining stock should be quarantined and
returned. Full details of the drug alert are included in the attached PDF file. Please forward to listed recipients. This information is also published on the MHRA website https://www.gov.uk/drug-device-alerts.
|
| Additional information: |
|
NHS England and NHS Improvement Regional Offices: Please cascade this alert to Community Pharmacies not yet registered with CAS.
GP Practices: Please note this alert is for Dispensing GP Practices only.
|
| Cascade to: |
|
- #COMMUNITYPHARMACISTS#
- #DISPENSING GP#
- #HospitalPharmacy#
|